ArticleNature communications2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.
Mitchell J Elliott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it